Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2715-2724

  Costa Garcia, Marcel ^a   Vera, Andrea ^a   Moraru, Manuela ^b   Vilches, Carlos ^b   López Botet, Miguel ^a,b   Muntasell, Aura ^c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; GRANZYME B; HLA B ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; KLRC2 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; VIRUS ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; ANTIBODY PRODUCTION; CELL CULTURE; CELL LINE; CYTOMEGALOVIRUS; FIBROBLAST; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; VIROLOGY;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, IGE; TUMOR NECROSIS FACTOR-ALPHA; VIRION;

EID: 84923852558     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402281     Document Type: Article

References (56)

1. Crumpacker, C. S. 2000. Cytomegalovirus. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th Ed., Vol. 5. G. L. Mandell, J. E. Bennet, and R. Dolin, eds. Churchill Livingstone, Philadelphia, p. 1586-1599.
2. Boeckh, M., and P. Ljungman. 2009. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113: 5711-5719.
3. Fishman, J. A. 2007. Infection in solid-organ transplant recipients. N. Engl. J. Med. 357: 2601-2614.
4. Pass, R. F., K. B. Fowler, S. B. Boppana, W. J. Britt, and S. Stagno. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35: 216-220.
5. Pawelec, G., and E. Derhovanessian. 2011. Role of CMV in immune senescence. Virus Res. 157: 175-179.
6. Romo, N., M. Fitó, M. Gumá, J. Sala, C. Garcýa, R. Ramos, A. Muntasell, R. Masiá, J. Bruguera, I. Subirana, et al. 2011. Association of atherosclerosis with expression of the LILRB1 receptor by human NK and T-cells supports the infectious burden hypothesis. Arterioscler. Thromb. Vasc. Biol. 31: 2314-2321.
7. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
8. Loh, J., D. T. Chu, A. K. O'Guin, W. M. Yokoyama, and H. W. Virgin, IV. 2005. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79: 661-667.
9. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
10. López-Botet, M., and T. Bellón. 1999. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 11: 301-307.
11. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633.
12. Tortorella, D., B. Gewurz, D. Schust, M. Furman, and H. Ploegh. 2000. Downregulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology. Immunol. Invest. 29: 97-100.
13. López-Botet, M., A. Angulo, and M. Gumá. 2004. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 63: 195-203.
14. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
15. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
16. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
17. Muntasell, A., C. Vilches, A. Angulo, and M. López-Botet. 2013. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 43: 1133-1141.
18. Della Chiesa, M., M. Falco, A. Bertaina, L. Muccio, C. Alicata, F. Frassoni, F. Locatelli, L. Moretta, and A. Moretta. 2014. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/-umbilical cord blood. J. Immunol. 192: 1471-1479.
19. Zhang, T., J. M. Scott, I. Hwang, and S. Kim. 2013. Cutting edge: antibodydependent memory-like NK cells distinguished by FcRg deficiency. J. Immunol. 190: 1402-1406.
20. Foley, B., S. Cooley, M. R. Verneris, M. Pitt, J. Curtsinger, X. Luo, S. Lopez-Vergès, L. L. Lanier, D. Weisdorf, and J. S. Miller. 2012. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119: 2665-2674.
21. Lopez-Vergès, S., J. M. Milush, B. S. Schwartz, M. J. Pando, J. Jarjoura, V. A. York, J. P. Houchins, S. Miller, S. M. Kang, P. J. Norris, et al. 2011. Expansion of a unique CD57.NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
22. Monsiváis-Urenda, A., D. Noyola-Cherpitel, A. Hernández-Salinas, C. Garcýa-Sepúlveda, N. Romo, L. Baranda, M. López-Botet, and R. González-Amaro. 2010. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 40: 1418-1427.
23. Noyola, D. E., C. Fortuny, A. Muntasell, A. Noguera-Julian, C. Muñoz-Almagro, A. Alarcón, T. Juncosa, M. Moraru, C. Vilches, and M. López-Botet. 2012. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 42: 3256-3266.
24. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
25. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
26. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
27. Kuijpers, T. W., P. A. Baars, C. Dantin, M. van den Burg, R. A. van Lier, and E. Roosnek. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
28. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderýas, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirusinfected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
29. Wu, Z., C. Sinzger, G. Frascaroli, J. Reichel, C. Bayer, L. Wang, R. Schirmbeck, and T. Mertens. 2013. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 87: 7717-7725.
30. Muntasell, A., M. López-Montañés, A. Vera, G. Heredia, N. Romo, J. Peñafiel, M. Moraru, J. Vila, C. Vilches, and M. López-Botet. 2013. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 43: 3268-3278.
31. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166.
32. Fauriat, C., E. O. Long, H. G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167-2176.
33. Vilches, C., J. Castaño, P. Muñoz, and J. Peñalver. 2008. Simple genotyping of functional polymorphisms of the human immunoglobulin G receptors CD16A and CD32A: a reference cell panel. Tissue Antigens 71: 242-246.
34. Bryceson, Y. T., M. E. March, D. F. Barber, H. G. Ljunggren, and E. O. Long. 2005. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202: 1001-1012.
35. Couzi, L., V. Pitard, X. Sicard, I. Garrigue, O. Hawchar, P. Merville, J. F. Moreau, and J. Déchanet-Merville. 2012. Antibody-dependent anticytomegalovirus activity of human gd T cells expressing CD16 (FcgRIIIa). Blood 119: 1418-1427.
36. Rice, G. P., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediateearly gene products. Proc. Natl. Acad. Sci. USA 81: 6134-6138.
37. Sinzger, C., M. Digel, and G. Jahn. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325: 63-83.
38. Forthal, D. N., T. Phan, and G. Landucci. 2001. Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells. Transpl. Infect. Dis. 3(Suppl. 2): 31-34.
39. Lang, P., A. Griesinger, K. Hamprecht, T. Feuchtinger, M. Schumm, F. Neuhäuser, J. Greil, D. Martin, R. Handgretinger, and D. Niethammer. 2004. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. Hum. Immunol. 65: 423-431.
40. Ahmad, R., S. T. Sindhu, E. Toma, R. Morisset, J. Vincelette, J. Menezes, and A. Ahmad. 2001. Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J. Clin. Immunol. 21: 227-233.
41. Isitman, G., I. Stratov, and S. J. Kent. 2012. Antibody-dependent cellular cytotoxicity and NK cell-driven immune escape in HIV infection: implications for HIV vaccine development. Adv. Virol. 2012: 637208.
42. Mabuka, J., R. Nduati, K. Odem-Davis, D. Peterson, and J. Overbaugh. 2012. HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog. 8: e1002739.
43. Srivastava, V., Z. Yang, I. F. Hung, J. Xu, B. Zheng, and M. Y. Zhang. 2013. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus. J. Virol. 87: 5831-5840.
44. Jegaskanda, S., P. C. Reading, and S. J. Kent. 2014. Influenza-specific antibodydependent cellular cytotoxicity: toward a universal influenza vaccine. J. Immunol. 193: 469-475.
45. Ameres, S., J. Mautner, F. Schlott, M. Neuenhahn, D. H. Busch, B. Plachter, and A. Moosmann. 2013. Presentation of an immunodominant immediate-early CD8 + T cell epitope resists human cytomegalovirus immunoevasion. PLoS Pathog. 9: e1003383.
46. Chambers, J., A. Angulo, D. Amaratunga, H. Guo, Y. Jiang, J. S. Wan, A. Bittner, K. Frueh, M. R. Jackson, P. A. Peterson, et al. 1999. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73: 5757-5766.
47. Budt, M., H. Reinhard, A. Bigl, and H. Hengel. 2004. Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? Int. Immunopharmacol. 4: 1135-1148.
48. Corrales-Aguilar, E., M. Trilling, K. Hunold, M. Fiedler, V. T. Le, H. Reinhard, K. Ehrhardt, E. Mercé-Maldonado, E. Aliyev, A. Zimmermann, et al. 2014. Human cytomegalovirus Fcg binding proteins gp34 and gp68 antagonize Fcg receptors I, II and III. PLoS Pathog. 10: e1004131.
49. Lin, L., C. Ma, B. Wei, N. Aziz, R. Rajalingam, S. Yusung, H. A. Erlich, E. A. Trachtenberg, S. R. Targan, D. P. McGovern, et al. 2014. Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function. J. Immunol. 193: 940-949.
50. Luetke-Eversloh, M., Q. Hammer, P. Durek, K. Nordström, G. Gasparoni, M. Pink, A. Hamann, J. Walter, H. D. Chang, J. Dong, and C. Romagnani. 2014. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 10: e1004441.
51. Hwang, I., T. Zhang, J. M. Scott, A. R. Kim, T. Lee, T. Kakarla, A. Kim, J. B. Sunwoo, and S. Kim. 2012. Identification of human NK cells that are deficient for signaling adaptor FcRg and specialized for antibody-dependent immune functions. Int. Immunol. 24: 793-802.
52. Hatjiharissi, E., L. Xu, D. D. Santos, Z. R. Hunter, B. T. Ciccarelli, S. Verselis, M. Modica, Y. Cao, R. J. Manning, X. Leleu, et al. 2007. Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcgammaRIIIa-158 V/V and V/F polymorphism. Blood 110: 2561-2564.
53. Koene, H. R., M. Kleijer, J. Algra, D. Roos, A. E. von dem Borne, and M. de Haas. 1997. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 90: 1109-1114.
54. Mellor, J. D., M. P. Brown, H. R. Irving, J. R. Zalcberg, and A. Dobrovic. 2013. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J. Hematol. Oncol. 6:1-6.
55. Muntasell, A., M. Costa-Garcia, A. Vera, N. Marina-Garcia, C. J. Kirschning, and M. López-Botet. 2013. Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front. Immunol. 4: 40.
56. Martýnez-Rodrýguez, J. E., J. Munné-Collado, R. Rasal, E. Cuadrado, L. Roig, A. Ois, A. Muntasell, T. Baro, F. Alameda, J. Roquer, and M. López-Botet. 2013. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. Arterioscler. Thromb. Vasc. Biol. 33: 2653-2659.